Abstract
In our “Discussion on the mode of action of anti-inflammatory drugs” (in this book) it is pointed out that the therapeutic effects of aspirin-like drugs are symptomatic. These drugs do not interfere with the evolution of the chronic processes but act on the expression of some inflammatory signs and symptoms. Possibly, most of the therapeutic use of aspirin-like drugs in many diseases is due to their antialgic effect rather than to their anti-oedematogenic properties. If one day, we have drugs which really interfere with the progression of chronic diseases, aspirin-like drugs, i.e. cyclo-oxygenase inhibitors, will be classified as pseudo-anti-inflammatory drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
V. A. Alabaster and Y. S. Bakhle. Release of smooth muscle-contracting substances from isolated perfused lungs. Europ. J. Pharmac., 35: 349–360 (1976).
C. R. Beddell, R. L. Follenfant, L. A. Lowe, F. B. Ubatuba, S. Wilkinson and R. J. Miller. Analogues of the enkephalins -Structural requirements for opioid activity. In: “Biological Activity and Chemical Structure”. J. A. Keverling Buisman, ed., Elvesier Scientific Publishing Company, New York, pp. 177–193 (1977).
W. C. Chang, S. Murota and S. Tsurufugi. A new prostaglandin transformed from arachidonic acid in carrageenin-induced granuloma. Biochem. Biophys. Res. Comm., 72: 1259–1264 (1976).
M. L. Cohn, M. Cohn and F. H. Taylor. Guanosine 3’, 5’ monophosphate: A central nervous system regulator of analgesia. Science, 199: 319–322 (1978).
H. O. Collier and A. C. Roy. Inhibition of E- rostaglandins sensitive adenyl cyclase as the mechanism of morphine analgesia. Prostaglandins, 7: 361–376 (1974).
A. Dembiska-Kiec, A. Zmuda and J. Krupinska. Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations. In: “Advances in Prostaglandins and Thromboxane Research”, vol. 1. B. Samuelsson and R. Paoletti, eds., Raven Press, New York, pp. 99–103 (1976).
J. C. Eccles and P. L. Mcgeer. Ionotropic and metabotropic transmission. Trends in Neurosciences, 2: 39–40 (1979).
J. Faires and D. J. McCarty. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet, 11: 682–685 (1962).
S. Ferri, A. Santagostino, P. C. Braga and I. Galatelas. Decrease antinociceptive effect of morphine in rats treated intraventricularly with prostaglandin El. Psychopharmacologia (Berl.), 39: 231–235 (1974).
S. H. Ferreira. Prostaglandins, aspirin-like drugs and analgesia. Nature, New Biol., 240: 200–203 (1972).
S. H. Ferreira and M. Nakamura. Prostaglandin hiperalgesia: I, A cAMP/Ca2 dependent process; II, The peripheral analgesic activity of morphine, enkephalins and opioid antagonists; III, Relevance of the peripheral effect for the analgesic action of opioid antagonists. Prostaglandins, in press (1979).
S. H. Ferreira and J. R. Vane. Mode of action of anti-inflammatory agents which are prostaglandin synthetase inhibitors. In: “Anti-Inflammatory Drugs”, J. R. Vane and S. H. Ferreira, eds., Handbook of Experimental Pharmacology, vol. 50/II - Springer Verlag, Berlin, Heidelberg, pp. 348–398 (1978).
S. H. Ferriera, B. B. Lorenzetti and F. M. A. Correa. Central and peripheral antialgesic action of aspirin-like drugs. European J. Pharmacol., 53: 39–48 (1978).
S. H. Ferreira, S. Moncada and J. R. Vane. Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen. Br. J. Pharmac., 47: 48–58 (1973).
S. H. Ferreira, S. Moncada and J.R. Vane. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br. J. Pharmac., 49: 86–97 (1973).
S. H. Ferreira, M. Nakamura and M. S. A. Castro. The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins, 16: 31–37 (1978).
R. J. Flower and J. R. Vane. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamido - phenol). Nature, 240: 410–411 (1972).
N. D. Goldberg, M. K. Haddox, S. E. Nicol, D. B. Glass, C. H. Sanford, F. A. Kuehl Jr. and R. Estensen. Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: The yin yang hypothesis. In: “Advances in Cyclic Nucleotides Research”, G. I. Drummond, P. Greengard and G. A. Robinson, eds. Raven Press, New York, vol. 5 pp. 307–330 (1975).
A. G. Herman and S. Moncada. Release of prostaglandins and incapacitation after injection of endotoxin in the knee joint of the dog. Br. J. Pharmac., 53: 465p (1975).
H. Juan and F. Lembeck. Action of peptides and other algesic agents on paravascular pain receptors on the isolated perfused rabbit ear. Naunym-Schmiedeberg`s Arch. Pharmac., 283: 151–164 (1974).
H. Juan and F. Lembeck. Inhibition of action of Eprostaglandins (PGs) on paravascular pain receptors. Naunym-Schmiedebergs Arch. Pharmac., 285: R36 (1974).
J. Knoll, S. Furst and S. Makleits. The pharmacology of N-substituted azido-morphines. Arch. Ínt. Pharmacodyn., 228: 268–292 (1977).
L. Lasagna. The clinical pharmacology of analgesics and analgesic antagonists. In: “Proc. of the 3rd International Pharmacol. Meeting”, R. K. S. Lim, ed. Pergamon Press,Oxford, vol. 9: 113–120 (1968).
R. K. S. Lim, F. Guzman, D. W. Rodgers, K. Goto, G. Braun, G. D. Dickerson and R. J. Engle. Site of action of narcotic and non-narcotic analgesics determined by blocking bradykinin-evoked visceral pain. Arch. Int. Pharmacodyn., 152: 25–59 (1964).
W. R. Martin. Opioids antagonists. Pharmacol. Reviews, 4: 463–521 (1967).
S. Moncada, S. H. Ferreira and J. R. Vane. Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Europ. J. Pharmacol., 31: 250–260 (1975).
E. R. Perl. Sensitization of nociceptors and its relation to sensation. In: “Advances in Pain Research and Therapy”, J. J. Bonica and D. Albe-Fessard, eds., Raven Press, New York, vol. I, pp. 17–34 (1976).
L. 0. Randall and J. J. Selitto. A method for measurement of analgesic activity on inflammed tissue. Arch. Int. Pharmacodyn., 111: 409–419 (1957).
M. E. Rosenthale, A. Dervinis, J. Kassarich and S. Singer. Prostaglandins and anti-inflammatory drugs in the dog knee joint. J. Pharm.Pharmac., 24: 149–152 (1972).
E. W. Sutherland, G. A. Robison and R. W. Butcher. Some aspects of the biological role of adenosine 3’, 5’monophosphate (Cyclic AMP). Circulation, 37: 279–306 (1968).
J. W. Ward, M. Foxwell and W. H. Funderburk. The detection of analgesia produced by morphine antagonists in laboratory animals. Pharmacologist, 7: 163 (1965).
A. L. Willis and M. Cornelsen. Repeated injection of prostaglandin E2 in rat paw induced chronic swelling and marked decrease in pain threshold. Prostaglandins, 3: 353–357 (1973).
C. A. Winter and L. Flataker. Reaction thresholds to pressure in edematous hindpaws of rats and responses to analgesic drugs. J. Pharmacol. Exp. Therapeutics, 150: 165–171 (1965).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Ferreira, S.H. (1981). Prostaglandins and Inflammatory Hyperalgesia. In: Berti, F., Velo, G.P. (eds) The Prostaglandin System. NATO Advanced Study Institutes Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3896-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3896-3_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3898-7
Online ISBN: 978-1-4684-3896-3
eBook Packages: Springer Book Archive